A Study on the Effects on Glucose Regulation, Inflammation and Serum Lipids After Fish Protein Supplementation in Elderly (GRIPE)
NCT ID: NCT03529344
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2016-08-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study will investigate the effects of a protein hydrolysate from blue whiting, a fish species normally used to produce fish meal for aquaculture industry, on glucose homeostasis, inflammation and serum lipids in elderly nursing home residents.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I
NCT03669796
Effect Study of Marine Protein Hydrolysates to Prevent Loss of Muscle Mass and Physical Function in Frail Elderly
NCT02890290
Effect of a Protein-enriched Drink on Muscle Function
NCT02385357
Distribution of Nutrient Derived Amino Acids
NCT03870425
Acute Effects of Different Protein Sources and Different Glycemic Index on Energy Balance, Glucose Allostasis and Amino Acid Metabolism: a Randomized, 4-condition, Two Cross-over Study in Adults.
NCT02770833
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blue whiting protein hydrolysate
Dietary Supplement: Blue whiting protein hydrolysate 6g protein per day for 6wk
Blue whiting protein hydrolysate
Dietary Supplement: Blue whiting protein hydrolysate 6g protein per day for 6wk
Placebo Comparator: Control
Control group will receive non-caloric juice without protein supplementation
Placebo Comparator: Control
Control group will receive non-caloric juice without protein supplementation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blue whiting protein hydrolysate
Dietary Supplement: Blue whiting protein hydrolysate 6g protein per day for 6wk
Placebo Comparator: Control
Control group will receive non-caloric juice without protein supplementation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* both genders
* nursing home resident
Exclusion Criteria
* severe cognitive impairment
* allergies towards fish, milk, egg
* weight loss \>5% last 3 months
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bergen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oddrun Anita Gudbrandsen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oddrun A Gudbrandsen, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bergen
References
Explore related publications, articles, or registry entries linked to this study.
Drotningsvik A, Oterhals A, Flesland O, Nygard O, Gudbrandsen OA. Fish protein supplementation in older nursing home residents: a randomised, double-blind, pilot study. Pilot Feasibility Stud. 2019 Feb 26;5:35. doi: 10.1186/s40814-019-0421-x. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/75
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.